Extensive drug resistance in TB is not a new phenomenon. It is created when patients with multidrug-resistant TB (MDR-TB) are treated with second-line anti-TB drugs but fail to be cured. The first ...

Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from complex samples // Panel significantly accelerates TB outbreak tracking and ...

Tuberculosis (TB) remains a global health challenge, affecting millions each year. In 2023, an estimated 10.8 million people contracted TB, with 1.25 million deaths, according to the World Health ...

Tuberculosis (TB) is still a first-class public health priority, representing the leading cause of death at global level. According to the World Health Organization (WHO), as many as 9.6 million new ...

One in five multi-drug resistant (MDR) tuberculosis (TB) cases in children under the age of 15 could be averted every year by household contact management, according to a new modeling study published ...

Mobile healthcare tools, from video observation to direct and indirect device monitoring via sensors, hold promise for tuberculosis treatment--however, ethical concerns remain. Researchers from the ...

Recent Updates in Basic Research, Drug Discovery and Treatment - Volume II", we are pleased to announce the launch ...

A TB patient receiving counseling and treatment at Kerugoya Hospital TB Management Center. [Jane Mugambi, Standard] African countries should increase their investment in Tuberculosis and especially in ...

Tuberculosis (TB) remains a major problem in the South African mining sector; infection rates are 10 times higher than the rate the WHO classifies as an emergency. The Southern Africa TB in the Mining ...

Identifying XDR-TB is not an easy task. Patients with the highest risk of developing XDR-TB are those MDR-TB patients who failed treatment using a second-line regimen and TB patients who have a ...